PYY and schizophrenia: In our study, it was planned to compare the levels of asprosin, PYY, body mass index (BMI), and metabolic parameters such as lipid profiles, blood sugar, glycated hemoglobin (HbA1c) between schizophrenia patients in the acute phase, schizophrenia patients in remission, and healthy controls without additional psychopathology or metabolic disease.